RCPA provides guidence on Serum Tumour Marker
16 November, 2016

The Royal College of Pathologists of Australasia (RCPA) has announced a new position statement, outlining its recommendations on the requesting, testing and reporting of serum tumour markers, specifically related to the testing of serum specimens (not urine, tissue or cells). The appropriate use of tumour marker testing is complex and the new guidelines have been created to reduce the risk of patient harm which may occur when testing is performed inappropriately. The recommendations do not include markers such as prostate specific antigen or hormones, although the principles described with respect to tumour marker testing and the reporting of results may still apply.

Go Back

Page last updated:

Copyright © 2020 RCPA. All rights reserved.